Yanjun Hou to Neoadjuvant Therapy
This is a "connection" page, showing publications Yanjun Hou has written about Neoadjuvant Therapy.
Connection Strength
0.291
-
Hou Y, Nitta H, Wei L, Banks PM, Parwani AV, Li Z. Evaluation of Immune Reaction and PD-L1 Expression Using Multiplex Immunohistochemistry in HER2-Positive Breast Cancer: The Association With Response to Anti-HER2 Neoadjuvant Therapy. Clin Breast Cancer. 2018 Apr; 18(2):e237-e244.
Score: 0.147
-
Hou Y, Nitta H, Wei L, Banks PM, Portier B, Parwani AV, Li Z. HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma. Breast Cancer Res Treat. 2017 Nov; 166(2):447-457.
Score: 0.144